Your browser doesn't support javascript.
loading
mTOR kinase activity disrupts a phosphorylation signaling network in schizophrenia brain.
Chadha, Radhika; Alganem, Khaled; Mccullumsmith, Robert E; Meador-Woodruff, James H.
Affiliation
  • Chadha R; Department of Neurobiology, University of Utah, Salt Lake City, UT, USA. radhika.chadha@neuro.utah.edu.
  • Alganem K; Department of Neurosciences, University of Toledo College of Medicine, Toledo, OH, USA.
  • Mccullumsmith RE; Department of Neurosciences, University of Toledo College of Medicine, Toledo, OH, USA.
  • Meador-Woodruff JH; Neurosciences Institute, ProMedica, Toledo, OH, USA.
Mol Psychiatry ; 26(11): 6868-6879, 2021 11.
Article in En | MEDLINE | ID: mdl-33990769
The AKT-mTOR signaling transduction pathway plays an important role in neurodevelopment and synaptic plasticity. mTOR is a serine/threonine kinase that modulates signals from multiple neurotransmitters and phosphorylates specific proteins to regulate protein synthesis and cytoskeletal organization. There is substantial evidence demonstrating abnormalities in AKT expression and activity in different schizophrenia (SZ) models. However, direct evidence for dysregulated mTOR kinase activity and its consequences on downstream effector proteins in SZ pathophysiology is lacking. Recently, we reported reduced phosphorylation of mTOR at an activating site and abnormal mTOR complex formation in the SZ dorsolateral prefrontal cortex (DLPFC). Here, we expand on our hypothesis of disrupted mTOR signaling in the SZ brain and studied the expression and activity of downstream effector proteins of mTOR complexes and the kinase activity profiles of SZ subjects. We found that S6RP phosphorylation, downstream of mTOR complex I, is reduced, whereas PKCα phosphorylation, downstream of mTOR complex II, is increased in SZ DLPFC. In rats chronically treated with haloperidol, we showed that S6RP phosphorylation is increased in the rat frontal cortex, suggesting a potential novel mechanism of action for antipsychotics. We also demonstrated key differences in kinase signaling networks between SZ and comparison subjects for both males and females using kinome peptide arrays. We further investigated the role of mTOR kinase activity by inhibiting it with rapamycin in postmortem tissue and compared the impact of mTOR inhibition in SZ and comparison subjects using kinome arrays. We found that SZ subjects are globally more sensitive to rapamycin treatment and AMP-activated protein kinase (AMPK) contributes to this differential kinase activity. Together, our findings provide new insights into the role of mTOR as a master regulator of kinase activity in SZ and suggest potential targets for therapeutic intervention.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia Type of study: Prognostic_studies Limits: Animals Language: En Journal: Mol Psychiatry Journal subject: BIOLOGIA MOLECULAR / PSIQUIATRIA Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia Type of study: Prognostic_studies Limits: Animals Language: En Journal: Mol Psychiatry Journal subject: BIOLOGIA MOLECULAR / PSIQUIATRIA Year: 2021 Type: Article Affiliation country: United States